Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 284-461-5 | CAS number: 84896-44-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicity to reproduction
Administrative data
- Endpoint:
- reproductive toxicity, other
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24 June 2016 - 10 December 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- The study has been conducted on the structural analogue substance DBTE (CAS 10584-98-2) which shows in a simulated gastric hydrolysis study similar metabolites as the registered substance.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD TG 414
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 2-ethylhexyl 4,4-dibutyl-10-ethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
- EC Number:
- 234-186-1
- EC Name:
- 2-ethylhexyl 4,4-dibutyl-10-ethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
- Cas Number:
- 10584-98-2
- Molecular formula:
- C28H56O4S2Sn
- IUPAC Name:
- 2-ethylhexyl 4,4-dibutyl-10-ethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecan-1-oate
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- DBTE > 95 %
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- In-house bred animals (healthy, yound adult animals)
4 Groups 25 pregnant females per group
110 female and 55 males were received. Males were used for cohabitation with females. After cohab
itation, all males, extra mated and non mated females were euthanized under CO2 anesthesia.
Age at initiation of mating: 10 to 12 weeks
Animal Identification: Acclimatisation period: Cage cards and tail marking by marker pen. Treatment
period: cage cards and body marking by tumeric solution.
Animals were housed under standard laboratory conditions, air-conditioned with adequate fresh air su
pply (12-15 Air changes per hour), room temperature 19.8 to 22.6 oC and relative humidity 49 to 68%
, with 12 hours fluorescent light and 12 hours dark cycle. The temperature and relative humidity were
recorded once daily.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- peanut oil
- Details on exposure:
- Test Item formulation was prepared daily before administration. The required quantity of test item was
weighted into a clean beaker and there by adding little volume of peanut oil (vehicle) in to the beaker
and was mixed well with glass rod and transferred into a measuring cylinder. The beaker was rinsed
with peanut oil and the volume was transferred to measuring cylinder. This procedure was repeated
until to ensure entire quantity of test item formulation was transferred into measuring cylinder. Fin
ally the volume was made up to required quantity with peanut oil to get a desired concentration of
different dose levels - Details on mating procedure:
- After minimum five days of acclimatization period, males and females were cohabitated at 1:2 ratio (one male and two females) until evidence of copulation is observed to obtain the required number ofpregnant rats for each group or for two weeks. Every morning, the vaginal smear of each female wasexamined for presence of sperm in the vaginal smear and/or vaginal plug. The day of confirmation of mating was designated as day ‘0’ of gestation. Each day, the body weight of mated rats (day 0 pregnant females) was recorded and arranged in the ascending order of their body weight. These matedfemales were evenly distributed to all the groups based on their body weights so as to maintaincomparable mean body weight for all groups and permanent identification numbers were assigned.
Animals were kept for mating in seven batches to regulate the number of animals sacrificed on a particular day.
Females not mated within 14 days of pairing with the first male were placed with a second provenmale.
After obtaining required number of pregnant females for each group, the extra mated, non-matedfemales and all males were sacrificed without recording any observations - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Formulation analysis for dose concentration verification was was performed for all dose formulations during week 1 and week 4 of dosing period. The dose formulation samples were collected in duplicates (2 x 5 ml ) for each dose formulation including vehicle control and transferred at ambient conditions for dose confirmation analysis at Auriga Research ltd, Unit-III, No 136, 6th Cross, 2nd stage,Yeshwanthpur industrial suburb, Bangalore-560022.
The samples are analyzed for tin content by ICP-OES and the results found to be within the acceptance range of +/- 10 % of the nominal conjcentration.
Results in Appendix 14 of the report - Duration of treatment / exposure:
- GD 5 to 19
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- G1 Vehicle Control
- Dose / conc.:
- 2.5 mg/kg bw/day (nominal)
- Remarks:
- G2 Low Dose
- Dose / conc.:
- 8.5 mg/kg bw/day (nominal)
- Remarks:
- G3 Mid Dose
- Dose / conc.:
- 25 mg/kg bw/day (nominal)
- Remarks:
- G4 High Dose
- No. of animals per sex per dose:
- 25 mated females
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- Treatment Group Description Dose (mg/kg bw) Concentration (mg/ml) No of preg. fem.
Vehicle G1 Control 0 0 25
DBTE G2 Low Dose 2.5 0.5 25
DBTE G3 Mid Dose 8.5 1.7 25
DBTE G4 High Dose 25.0 5.0 25
Examinations
- Parental animals: Observations and examinations:
Clinical Signs of Toxicity and Mortality/Morbidity
All animals were observed once daily for clinical signs of toxicity and twice daily for mortality/morbidity.
Body Weight
Individual animal body weight was weighed on Gestation Days (GD) 0, 3, and daily from DG 5 to 20 (day of caesarian section)
Feed Consumption
Individual animal feed intake of mated females was recorded for days 0 to 3, 3 to 5 and daily from day5 to 20 of gestation.- Postmortem examinations (parental animals):
- Necropsy
All surviving animals were anaesthetized by exposing to CO2 and subjected to detailed necropsy on
the day (GD 20) of cesarean section. The Thymus gland of each rat was weighed and recorded. The
Thymus gland, ovary and uterus were collected and preserved in 10% neutral buffered formalin so
lution for microscopic examination. - Reproductive indices:
- Uteri Observations
On the 20th day of gestation, fetuses were taken out by cesarean section and females were subjecte
d to macroscopic examination. The uteri of non-pregnant females were immersed in 10% ammonium
sulphide and there was no evidence of implantation sites. The weight of the gravid uterus including
cervix was recorded for each pregnant female at hysterectomy. The following counts/observations
were performed for all pregnant animals.
• No. of corpora lutea
• No. of implantations
• No. of live and dead fetuses
• No. of early and late resorptions - Offspring viability indices:
- • Sex, number and weight of live fetuses
• External appearance of live fetuses (including oral cavity)
• External anomalies
• Crown-rump length
Live fetuses were killed by keeping them on cool packs and allocated to either skeletal or visceral exa
minations, independent of sex. Approximately one-half of live fetuses from each litter were examine
d for skeletal alterations. The remaining fetuses were examined for soft tissue alterations (visceral
examinations).
Visceral Examination
A detailed soft tissue examination was performed on the fresh fetuses with even numbers using micro
dissection technique (Staples technique) for body and a free-hand serial sectioning technique (Wilson
technique) for head.
After examination, the fetuses along with organs were preserved in a solution of glycerine. Obser
vations of visceral abnormalities and variations were recorded.
Skeletal Examination
The fresh fetuses with odd numbers were skinned and eviscerated, fixed in 95% ethanol, subjected to
preparation of Alcian blue staining for cartilage and Alizarin red S staining for bones and the specim
ens were examined under stereomicroscope for the presence or absence of skeletal malformation
(variations).
After examination, the fetuses were preserved in a solution of glycerine.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- The treatment related histopathological change of decreased cellularity in the thymic cortex was reported for 15/25 females of the high dose group. The observed decreased cell population in the cortex was described as multifocal to diffuse and severity varied from minimal to marked. The histopathological evaluation of the thymus was extended to the lower dose groups and there was no treatmentrelated changes observed in these animals.
Effect levels (P0)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 8.5 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- organ weights and organ / body weight ratios
- gross pathology
- histopathology: non-neoplastic
Results: F1 generation
Effect levels (F1)
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- > 25 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: The NOAEL of the test item for develomental toxicity was set to > 25 mg/kg bw, the high dose, because there were no adverse effects on fetal developmentals or incidences for external, soft tissueu or skeletal anomalies
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- no
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
